Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02975934
Title A Study of Rucaparib Versus Physician's Choice of Therapy in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency (TRITON3)
Recruitment Recruiting
Gender male
Phase Phase III
Variant Requirements Yes
Sponsors Clovis Oncology, Inc
Indications

prostate adenocarcinoma

prostate carcinoma

Therapies

Rucaparib

Docetaxel

Enzalutamide

Abiraterone

Age Groups: senior | adult
Covered Countries USA | CAN

Additional content available in CKB BOOST